Back
Genmab A/S Stock Predictions
Sponsored
GNMSF
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
37
GNMSF
Genmab A/S
Last Price:
290.40
Seasonality Move:
77.7%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereGenmab A/S Stock Forecast
- Over the next 52 weeks, Genmab A/S has on average historically risen by 27.5% based on the past 11 years of stock performance.
- Genmab A/S has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Genmab A/S Stock Undervalued?
The current Genmab A/S [GNMSF] share price is $290.34. The Score for GNMSF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - GNMSF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Genmab A/S Stock Go Up Next Year?
- Over the next 52 weeks, Genmab A/S has on average historically risen by 27.5% based on the past 11 years of stock performance.
Genmab A/S Stock Rating
Sell
37
Genmab A/S (GNMSF)
is a Sell
Is Genmab A/S overpriced?
- Genmab A/S has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Genmab A/S Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com
52-Week Data
52-Week High:
426.50
52-Week Low:
262.00
Prediction Charts
Market Cap:
18.94B
Price in USD:
290.34
Volume:
343
Beta:
0.65
Technical Analysis
SMA50:
292.00
SMA100:
296.89
SMA200:
324.67
52-Wk Change:
-29.67%
Stock Predictions
-
Is Genmab A/S stock public?
Yes, Genmab A/S is a publicly traded company. -
What is the Genmab A/S stock quote today?
The Genmab A/S stock price is 290.34 USD today. -
How to buy Genmab A/S stock online?
You can buy Genmab A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-4 | 302.30 | 297.17 | 306.55 | 297.17 |
Apr-5 | 304.20 | 293.25 | 304.20 | 293.25 |
Apr-8 | 292.79 | 291.92 | 303.71 | 291.92 |
Apr-9 | 292.21 | 296.00 | 300.90 | 292.21 |
Apr-10 | 289.77 | 297.74 | 302.35 | 289.77 |
Apr-11 | 306.17 | 298.16 | 306.17 | 294.75 |
Apr-12 | 292.51 | 291.12 | 297.46 | 290.92 |
Apr-15 | 295.59 | 282.00 | 295.59 | 278.46 |
Apr-16 | 295.94 | 285.11 | 295.94 | 285.11 |
Apr-17 | 282.20 | 281.02 | 292.85 | 278.65 |
Apr-18 | 281.08 | 290.38 | 290.38 | 279.82 |
Apr-19 | 287.06 | 284.55 | 288.30 | 283.30 |
Apr-22 | 279.76 | 289.67 | 290.53 | 279.76 |
Apr-23 | 280.41 | 290.34 | 294.54 | 279.36 |
Genmab A/S Earnings
Genmab A/S Earnings Report: Per Share Genmab A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Genmab A/S Forecast Revenue Growth
Genmab A/S Stock Analysis: Historical quarterly revenues per share for Genmab A/S and historical quarterly revenue growth:
* Genmab A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.